ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹22 Cr | ₹25 Cr | ₹13 Cr | ₹11 Cr | ₹19 Cr |
What is the latest Total Debt ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹25 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹19 Cr |
How is Total Debt of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹22 Cr | -14.24 | |
| Mar2024 | ₹25 Cr | 89.68 | |
| Mar2023 | ₹13 Cr | 21.01 | |
| Mar2022 | ₹11 Cr | -42.62 | |
| Mar2021 | ₹19 Cr | - | |
Compare Total Debt of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,245.1 Cr | -2.7% | -2.6% | 3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -2.7% |
-2.6% |
3.9% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses